DZ2514A1 - Dérivés substitués en c-4'de9-désoxo-9a-aza-9a-homoérythromycine a. - Google Patents

Dérivés substitués en c-4'de9-désoxo-9a-aza-9a-homoérythromycine a.

Info

Publication number
DZ2514A1
DZ2514A1 DZ980124A DZ980124A DZ2514A1 DZ 2514 A1 DZ2514 A1 DZ 2514A1 DZ 980124 A DZ980124 A DZ 980124A DZ 980124 A DZ980124 A DZ 980124A DZ 2514 A1 DZ2514 A1 DZ 2514A1
Authority
DZ
Algeria
Prior art keywords
homoerythromycin
deoxo
aza
substituted derivatives
derivatives
Prior art date
Application number
DZ980124A
Other languages
English (en)
French (fr)
Inventor
Brian Scott Bronk
Michael Anthony Letavic
Takushi Kaneko
Bingweivera Yang
Edward Alan Glazer
Hengmiao Cheng
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2514(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2514A1 publication Critical patent/DZ2514A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ980124A 1997-06-11 1998-06-10 Dérivés substitués en c-4'de9-désoxo-9a-aza-9a-homoérythromycine a. DZ2514A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
DZ2514A1 true DZ2514A1 (fr) 2003-02-01

Family

ID=21959336

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980124A DZ2514A1 (fr) 1997-06-11 1998-06-10 Dérivés substitués en c-4'de9-désoxo-9a-aza-9a-homoérythromycine a.

Country Status (50)

Country Link
US (4) US6420536B1 (es)
EP (1) EP0988310B9 (es)
JP (2) JP3315704B2 (es)
KR (1) KR100396168B1 (es)
CN (4) CN1243766C (es)
AP (1) AP1231A (es)
AR (1) AR013086A1 (es)
AT (1) ATE251173T1 (es)
AU (1) AU749816B2 (es)
BG (1) BG64391B1 (es)
BR (1) BRPI9810519B8 (es)
CA (1) CA2293823C (es)
CO (1) CO4950611A1 (es)
CZ (1) CZ298556B6 (es)
DE (2) DE122004000018I2 (es)
DK (1) DK0988310T3 (es)
DZ (1) DZ2514A1 (es)
EA (1) EA002441B1 (es)
EG (1) EG24081A (es)
ES (1) ES2205487T3 (es)
FR (1) FR04C0013I2 (es)
GT (1) GT199800077A (es)
HK (3) HK1028048A1 (es)
HN (1) HN1998000086A (es)
HR (1) HRP980314B1 (es)
HU (2) HU228005B1 (es)
ID (1) ID22992A (es)
IL (1) IL132809A0 (es)
IS (1) IS1998B (es)
LU (1) LU91076I9 (es)
MA (1) MA24564A1 (es)
ME (1) ME00876B (es)
MY (1) MY123354A (es)
NL (1) NL300150I2 (es)
NO (1) NO316911B1 (es)
NZ (2) NZ514871A (es)
OA (1) OA11224A (es)
PA (1) PA8452201A1 (es)
PE (1) PE79699A1 (es)
PL (1) PL191601B1 (es)
PT (1) PT988310E (es)
RS (1) RS49675B (es)
SI (1) SI0988310T1 (es)
SK (1) SK284171B6 (es)
TN (1) TNSN98082A1 (es)
TW (1) TW472060B (es)
UA (1) UA67744C2 (es)
UY (1) UY25040A1 (es)
WO (1) WO1998056802A1 (es)
ZA (1) ZA985017B (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
JP2001515865A (ja) * 1997-09-10 2001-09-25 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての９ａ−アザライド
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
IL145946A0 (en) * 1999-05-18 2002-07-25 Pfizer Prod Inc Novel crystalline forms of a macrolide antibiotic
WO2000071557A1 (en) * 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
JP2003507487A (ja) * 1999-08-24 2003-02-25 アボット・ラボラトリーズ 抗菌活性を有する９ａ−アザライド類
US6608033B1 (en) * 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
MXPA02007305A (es) 2000-01-27 2002-11-29 Pfizer Prod Inc Composiciones antiboticas de azalida.
SK14882002A3 (en) * 2000-04-27 2004-11-03 Pfizer Prod Inc The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
JP4104463B2 (ja) 2001-04-27 2008-06-18 ファイザー・プロダクツ・インク ４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
BRPI0416205A (pt) * 2003-11-21 2006-12-26 Pfizer Prod Inc uso de antibióticos como adjuvantes de vacina
EP2295422A3 (de) * 2004-03-16 2012-01-04 Boehringer Ingelheim International GmbH Glucopyranosylsubstituierte Benzolderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
ATE429921T1 (de) * 2005-01-14 2009-05-15 Glaxosmithkline Zagreb 9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2010048599A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating gastrointestinal diseases
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
NZ602544A (en) 2010-03-22 2014-11-28 Cempra Pharmaceuticals Inc Crystalline forms of a macrolide, and uses therefor
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
WO2012038372A1 (en) 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
WO2012051126A2 (en) * 2010-10-10 2012-04-19 Synovo Gmbh Anti-inflammatory macrolides
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法
EP3027634B1 (en) * 2013-07-31 2018-03-21 Farma GRS, d.o.o. Process for preparation of tulathromycin
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普（天津）生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
CN101691390A (zh) 2010-04-07
NO316911B1 (no) 2004-06-21
CN1172947C (zh) 2004-10-27
KR100396168B1 (ko) 2003-08-27
HRP980314B1 (en) 2004-04-30
CN1793155B (zh) 2010-05-12
IL132809A0 (en) 2001-03-19
ES2205487T3 (es) 2004-05-01
HUP0002209A2 (hu) 2000-12-28
DE122004000018I1 (de) 2004-09-30
HK1068893A1 (en) 2005-07-29
AU749816B2 (en) 2002-07-04
PT988310E (pt) 2003-12-31
ZA985017B (en) 1999-12-17
RS49675B (sr) 2007-11-15
UY25040A1 (es) 2000-09-29
ME00876B (me) 2012-06-20
GT199800077A (es) 1999-12-02
EP0988310B1 (en) 2003-10-01
CA2293823A1 (en) 1998-12-17
FR04C0013I1 (es) 2004-06-11
PL337505A1 (en) 2000-08-28
FR04C0013I2 (es) 2005-10-21
AP1231A (en) 2003-12-11
PA8452201A1 (es) 2000-05-24
DE122004000018I2 (de) 2011-01-13
IS1998B (is) 2005-03-15
US20020061858A1 (en) 2002-05-23
ID22992A (id) 1999-12-23
US6936592B2 (en) 2005-08-30
WO1998056802A1 (en) 1998-12-17
EP0988310A1 (en) 2000-03-29
SK168399A3 (en) 2000-11-07
TNSN98082A1 (fr) 2005-03-15
EP0988310B9 (en) 2006-03-08
CN1566129A (zh) 2005-01-19
DE69818665D1 (de) 2003-11-06
AP9801255A0 (en) 1998-06-30
OA11224A (en) 2003-07-16
ATE251173T1 (de) 2003-10-15
AU7347598A (en) 1998-12-30
HN1998000086A (es) 1999-03-08
LU91076I2 (fr) 2004-07-05
EG24081A (en) 2008-05-11
KR20010013632A (ko) 2001-02-26
JP2002316933A (ja) 2002-10-31
NL300150I1 (nl) 2004-08-02
DE69818665T2 (de) 2004-04-29
BRPI9810519B1 (pt) 2012-02-22
US6420536B1 (en) 2002-07-16
MY123354A (en) 2006-05-31
US6777393B2 (en) 2004-08-17
PE79699A1 (es) 1999-08-25
PL191601B1 (pl) 2006-06-30
EA002441B1 (ru) 2002-04-25
US20040180842A1 (en) 2004-09-16
BRPI9810519A (pt) 2000-09-19
US20040023896A1 (en) 2004-02-05
BRPI9810519B8 (pt) 2022-11-16
NZ514871A (en) 2003-08-29
CN1259136A (zh) 2000-07-05
CZ442199A3 (cs) 2000-07-12
NO996106L (no) 2000-02-10
NZ500660A (en) 2002-03-01
HUS1200028I1 (hu) 2016-08-29
NO996106D0 (no) 1999-12-10
EA199901015A1 (ru) 2000-06-26
SK284171B6 (sk) 2004-10-05
HU228005B1 (en) 2012-08-28
CO4950611A1 (es) 2000-09-01
UA67744C2 (uk) 2004-07-15
IS5252A (is) 1999-11-16
DK0988310T3 (da) 2003-12-15
HRP980314A2 (en) 1999-04-30
MA24564A1 (fr) 1998-12-31
YU58699A (es) 2002-08-12
CN1793155A (zh) 2006-06-28
NL300150I2 (nl) 2004-09-01
HK1028048A1 (en) 2001-02-02
HK1088014A1 (en) 2006-10-27
AR013086A1 (es) 2000-12-13
CN1243766C (zh) 2006-03-01
LU91076I9 (en) 2018-07-02
SI0988310T1 (en) 2004-02-29
CZ298556B6 (cs) 2007-11-07
TW472060B (en) 2002-01-11
JP2000514098A (ja) 2000-10-24
JP3315704B2 (ja) 2002-08-19
HUP0002209A3 (en) 2003-05-28
CA2293823C (en) 2004-02-17
BG64391B1 (bg) 2004-12-30
BG103945A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
DZ2514A1 (fr) Dérivés substitués en c-4'de9-désoxo-9a-aza-9a-homoérythromycine a.
CY2007024I1 (el) Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων
DE69832486D1 (de) C-4"-substitutierte macrolid-derivate
DZ2569A1 (fr) Dérivés 1,2,3,4-tétrahydronaphtalène substitués.
FR2690919B1 (fr) Dérivés de l'indole.
FR07C0051I2 (fr) Dérivés de l' Erythropoietine
DZ2495A1 (fr) Formule nouvelle de l'oméprazole-s.
ID20053A (id) Hipolipidemat 1,4-benzotiazepin-1,1-dioksida
DK0966477T3 (da) 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
FR2713641B1 (fr) Dérivés de l'épi-épibatidine.
DZ1985A1 (fr) Dérivés d'indole substitués.
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
DZ2597A1 (fr) Dérivés d'urée.
ATE243218T1 (de) 2''-deoxyhygromycinderivate
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
FR2721022B1 (fr) Dérivés de 5-imino 2-imidazolines fongicides.
BR1100301A (pt) Derivados de 3-azabiciclo (3.2.0) heptano n-substituìdos
BR1100649A (pt) Derivados de 10,11-metano dibenzo suberano
ES1038172Y (es) "caja-contenedor".